Lexi A.Heon

Associate

New York + 1.212.326.3423

Connect:

Share

Lexi Heon represents national and international companies in technology and life sciences-related licensing and technology transactions. She focuses her practice on intellectual property licensing and commercialization agreements, joint development agreements, and deal documents and due diligence associated with mergers and acquisitions. Lexi's experience ranges from representing clients in software and technology deals to clients in the health care and pharmaceutical industries.

Lexi also maintains an active pro bono practice, representing individuals seeking permanent residency status on behalf of Her Justice.

Prior to law school, Lexi worked as a chemist for Church & Dwight, an American consumer goods company.

Experience

  • Bose acquires McIntoshJones Day advised Bose Corporation in the acquisition of McIntosh Group, the parent company of high-performance and luxury audio brands that include McIntosh and Sonus faber.
  • Affiliates of Centre Lane Partners acquire substantially all of the assets of Hardinge Inc. and its subsidiaries, including the Kellenberger, USACH, SuperPrecision, and Workholding business linesJones Day advised affiliates of Centre Lane Partners in the acquisition of substantially all of the assets of Hardinge Inc. and its debtor subsidiaries, a global leader and provider of advanced machine tool, manufacturing and workholding solutions, as part of chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware.
  • TransDigm completes $1.5 billion Senior Secured Notes offering and incurs $1.5 billion of new term loans under its term credit facilityJones Day represented TransDigm Group Incorporated (“TransDigm Group”), a leading global designer, producer and supplier of highly engineered aircraft components, in connection with the Rule 144A and Regulation S offering by TransDigm Inc., its wholly-owned subsidiary, of $1.5 billion aggregate principal amount of 6.000% Senior Secured Notes due 2033 (the “Notes”).
  • Sanofi, Orano Med, and RadioMedix collaborate to develop radioligand therapiesJones Day represented and supported Sanofi's in-house team in connection with an exclusive licensing agreement with RadioMedix, Inc., and Orano Med, a subsidiary of the Orano Group.
  • Riverside portfolio company acquires Labor Law Center, LLCJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company OutSolve LLC of Labor Law Center, a premier leading provider of labor law compliance services.
  • Riverside portfolio company acquires Alexander GowJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Performance Systems Integration of Alexander Gow, which provides inspection, repair and installation of engineered and pre-engineered suppression systems for marine vessels, kitchen and special hazard applications in Washington, Oregon and Hawaii.
  • Riverside acquires CloudpermitJones Day represented The Riverside Company in its acquisition and financing of Cloudpermit, a community development software company for local governments, citizens, and other stakeholders.
  • Koch Equity Development acquires iconectiv, LLCJones Day is advising Koch Equity Development LLC, the principal investment and acquisition arm of Koch, Inc., on its acquisition of iconectiv, LLC ("iconectiv"), a telecommunications solutions leader, from Ericsson (NASDAQ: ERIC), the global supplier of mobile communication and connectivity solutions for service providers and enterprises, and affiliates of Francisco Partners, a leading technology investment firm.
    • View All

    September 2024 Blog

    Lack of Injury In Fact Scuttles Appeal, PTAB Litigation Blog

    December 2023 Commentary

    The CFTC Proposes Operational Resilience Framework for Swap Dealers and Futures Commission Merchants

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.